Citation:Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS, et al 2014

From Cancer Guidelines Wiki

Citation


Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS, et al. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncol 2014 Jan;15(1):96-105 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24332516.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
7.1 Considerations before selecting a surgical treatment modalityDr Albert Chetcuti BTech(Biotech) Hons, PhDcompleted
7.1 Considerations before selecting a surgical treatment modalityAnnika Stollerycompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What factors need to be considered when determining if surgical treatment modalities are optimal over non-surgical modalities for the management and/or treatment of BCC or SCC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What factors need to be considered when determining if surgical treatment modalities are optimal over non-surgical modalities for the management and/or treatment of BCC or SCC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What factors need to be considered when determining if surgical treatment modalities are optimal over non-surgical modalities for the management and/or treatment of BCC or SCC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What factors need to be considered when determining if surgical treatment modalities are optimal over non-surgical modalities for the management and/or treatment of BCC or SCC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. 7.1 Considerations before selecting a surgical treatment modality
  2. 8.5 Radiotherapy for actinic keratosis and cutaneous squamous cell carcinoma in situ